Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

JBI 2174

Next Previous
Drug Profile

JBI 2174

Alternative Names: JBI-2174

Latest Information Update: 28 Apr 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Jubilant Therapeutics
  • Class Antineoplastics; Small molecules
  • Mechanism of Action B7-H1 antigen inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Brain cancer; Brain metastases
  • Discontinued Gastrointestinal cancer

Most Recent Events

  • 28 Apr 2026 No recent reports of development identified for preclinical development in Brain metastases in USA (PO)
  • 28 Apr 2026 No recent reports of development identified for preclinical development in Brain-cancer in USA (PO)
  • 17 Feb 2023 Jubilant Therapeutics plans to file an IND application with the US FDA for Brain Metastasis and Brain cancer in the 2023 (Jubilant Therapeutics pipeline, February 2023)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top